Jim Donovan has worked in investment banking, investment management and corporate strategy for nearly two decades. He also shares his expertise in the classrooms of the University of Virginia where he serves as an adjunct professor.

“Jim’s experience in investment banking is a great fit with the FNIH board of directors, adding significant depth in the business arena,” according to Charles A. Sanders, MD, FNIH chairman. “I welcome him to the board and look forward to working with him.”

“I deeply respect the role the FNIH plays in supporting the NIH’s commitment to improving health, and am honored by this appointment,” says Donovan. “I’ve been an advocate of cancer research in particular for many years, and I’m excited to help support efforts in its treatment and prevention. I hope my background, experience and knowledge will serve the FNIH well as it continues to build strong partnerships to advance the NIH mission.”

“I nominated Jim because of his experience in the medical field and his extensive financial background,” says Paul M. Montrone, PhD, FNIH board treasurer. “His work as a trustee of The Dana-Farber Cancer Institute will bring an added dimension to the FNIH board of directors.”

Among the board members’ responsibilities are helping guide the FNIH’s mission and purpose; ensuring effective organizational planning; ensuring adequate resources and managing them effectively; reviewing, monitoring, and strengthening FNIH’s programs and services; and enhancing FNIH’s public standing.